Skip to main content
Livermore
Livermore
ZHEN

Geode Capital Management, LLC

SEC CIK
0001214717
Latest filing
Aug 12, 2026

UBX holding history

Unity Biotechnology, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

UBX overviewAll 13F holders of UBXFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of UBX by Geode Capital Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−169,025−100.0%Sold outHolders
Q2 2025169,025$64.2K<0.1%+2,812+1.7%AddedHolders
Q1 2025166,213$172.9K<0.1%+6,806+4.3%AddedHolders
Q4 2024159,407$155.7K<0.1%−3,835−2.3%ReducedHolders
Q3 2024163,242$240.0K<0.1%+14,199+9.5%AddedHolders
Q2 2024149,043$201.3K<0.1%+14,910+11.1%AddedHolders
Q1 2024134,133$220.0K<0.1%+2,351+1.8%AddedHolders
Q4 2023131,782$254.4K<0.1%00.0%UnchangedHolders
Q3 2023131,782$316.4K<0.1%+5,674+4.5%AddedHolders
Q2 2023126,108$321.6K<0.1%+3,125+2.5%AddedHolders
Q1 2023122,983$200.5K<0.1%+31,882+35.0%AddedHolders
Q4 202291,101$249.0K<0.1%+49,004+116.4%AddedConverted for a 1-for-10 splitHolders
Q3 2022420,973$166.0K<0.1%+3,333+0.8%AddedHolders
Q2 2022417,640$235.0K<0.1%−2,131−0.5%ReducedHolders
Q1 2022419,771$470.0K<0.1%+73,739+21.3%AddedHolders
Q4 2021346,032$505.0K<0.1%+27,359+8.6%AddedHolders
Q3 2021318,673$956.0K<0.1%+12,428+4.1%AddedHolders
Q2 2021306,245$1.42M<0.1%−248,870−44.8%ReducedHolders
Q1 2021555,115$3.33M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.